Rapid antimanic effect of risperidone monotherapy: A 3-week multicenter, double-blind, placebo-controlled trial Academic Article uri icon

Overview

MeSH Major

  • Antipsychotic Agents
  • Bipolar Disorder
  • Risperidone

abstract

  • Risperidone monotherapy was significantly more efficacious than placebo in the treatment of acute mania and demonstrated a rapid onset of action. Risperidone was well tolerated by patients in this study.

publication date

  • June 2004

Research

keywords

  • Academic Article

Identity

Language

  • eng

Digital Object Identifier (DOI)

  • 10.1176/appi.ajp.161.6.1057

PubMed ID

  • 15169694

Additional Document Info

start page

  • 1057

end page

  • 65

volume

  • 161

number

  • 6